Mostrando 5 resultados de: 5
Astemizole Synergizes Calcitriol Antiproliferative Activity by Inhibiting CYP24A1 and Upregulating VDR: A Novel Approach for Breast Cancer Therapy
ArticleAbstract: Background: Calcitriol antiproliferative effects include inhibition of the oncogenic ether-à-go-go-1Palabras claves:Autores:Avila-Chávez E., David B., Díaz L., Gamboa-Dominguez A., García-Becerra R., García-Quiroz J., Halhali A., Javier Camacho, Larrea F., Medina-Franco H., Ordaz-Rosado D., Rivas-Suárez M., Rodríguez P., Santos-Martínez N.Fuentes:scopusCalcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: A potential new therapeutic approach
ArticleAbstract: Background: Approximately 30% of breast tumors do not express the estrogen receptor (ER) α, which isPalabras claves:Breast Cancer, Calcitriol, Estrogen receptor, Hormonal therapy, VDRAutores:Avila-Chávez E., David B., Díaz L., Esparza-López J., García-Becerra R., García-Quiroz J., Halhali A., Ibarra-Sánchez M., Javier Camacho, Larrea F., Medina-Franco H., Ordaz-Rosado D., Santos-Martínez N.Fuentes:scopusEther à go-go potassium channels as human cervical cancer markers
ArticleAbstract: Ether à go-go (EAG) potassium channels display oncogenic properties. In normal tissues, EAG mRNA isPalabras claves:Autores:Avila-Chávez E., Cadena A., Camacho-Arroyo I., Díaz L., Dueñas-González A., Escamilla J., Farias L.M.B., Hernández-gallegos E., Hinojosa L.M., Javier Camacho, Lara G., Larrea F., Morales A., Ocaña D.B., Pardo L.A., Pérez-Cárdenas E., Sánchez-Peña L.C., Taja-Chayeb L., Vargas C., Villanueva L.A.Fuentes:scopusEstrogens and human papilloma virus oncogenes regulate human Ether-à-go-go-1 potassium channel expression
ArticleAbstract: Ether-à-go-go-1 (Eag1) potassium channels are potential tools for detection and therapy of numerousPalabras claves:Autores:Ahumada E., Alvarez-Rios E., Avila-Chávez E., Borja-Cacho E., Camacho-Arroyo I., Ceja-Ochoa I., David B., Díaz L., Escamilla J., Gamboa-Dominguez A., García-Becerra R., García-Latorre E., Garcia-Villa E., Gariglio P., Hernández-gallegos E., Javier Camacho, Larrea F., Morales A., Murbartián J., Ocadiz-Delgado R., Ordaz-Rosado D., Ortiz C.S., Restrepo-Angulo I., Rivera-Guevara C., Sánchez-Peña L.C., Saqui-Salces M., Uribe-Ramírez M., Vera E., Vizcaya-Ruiz A.D.Fuentes:scopusIn vivo dual targeting of the oncogenic ether-à-go-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumors
ArticleAbstract: Background: The oncogenic ether-à-go-go-1 potassium channel (EAG1) activity and expression are necesPalabras claves:Breast Cancer, Eag1, Ki-67, Targeted therapy, vitamin D, Vitamin D receptorAutores:Avila-Chávez E., David B., Díaz L., Esparza-López J., Gamboa-Dominguez A., García-Becerra R., García-Quiroz J., Halhali A., Ibarra-Sánchez M., Javier Camacho, Larrea F., Ordaz-Rosado D., Santos-Martínez N., Villanueva O.Fuentes:scopus